# Azithromycin in Atopic Dermatitis

> **NCT07713186** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Cairo University** · enrollment: 40 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Betamethasone or tacrolimus ointments
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT07713186
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07713186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07713186, "Azithromycin in Atopic Dermatitis". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07713186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*